Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$19.97 - $26.94 $284,792 - $384,191
-14,261 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$17.46 - $21.61 $248,997 - $308,180
14,261 New
14,261 $291,000
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $421,060 - $579,794
-26,768 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$13.54 - $26.41 $362,438 - $706,942
26,768 New
26,768 $455,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.